Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-22 Purchase |
2022-06-22 4:55 pm |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO |
30,000 | $0.57 | $17,100 | 210,207 (Indirect Direct) |
View |
| 2022-06-14 Purchase |
2022-06-15 4:05 pm |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO |
30,000 | $0.62 | $18,600 | 34,500 (Direct) |
View |
| 2021-08-19 Purchase |
2021-08-20 3:05 pm |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
8,000 | $1.225 | $9,800 | 18,000 (Direct) |
View |
| 2021-04-26 Purchase |
2021-04-26 6:16 pm |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. EVP, Chief Strategy Officer |
4,500 | $2.03 | $9,135 | 4,500 (Direct) |
View |
| 2021-04-20 Purchase |
2021-04-21 3:18 pm |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, CEO & President |
11,005 | $1.8 | $19,809 | 180,207 (Indirect Direct) |
View |
| 2021-04-16 Purchase |
2021-04-19 06:15 am |
Qualigen Therapeutics Inc. | QLGN | Lotz Christopher L. Vice President of Finance, CFO |
2,700 | $1.86 | $5,022 | 12,541 (Direct) |
View |
| 2020-12-29 Purchase |
2020-12-30 06:05 am |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
4,000 | $2.935 | $11,740 | 10,000 (Direct) |
View |
| 2020-11-20 Purchase |
2020-11-23 9:11 pm |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
6,000 | $3.4823 | $20,894 | 6,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-11 Option Award |
2022-08-04 4:17 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Abdul-Ahad Wajdi Vice President, R & D, CSO |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Lotz Christopher L. Vice President of Finance, CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | ARSHAD TARIQ SVP/Chief Medical Officer |
102,000 | $0 | 102,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Ritter Ira E. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | EMERY SIDNEY W JR Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | David Richard A. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Sinha Shishir K. VP, COO & Secretary |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO |
375,000 | $0 | 375,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 06:15 am |
N/A 2031-12-08 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/ChiefStrategyOfficer |
300,000 | $0 | 304,500 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 06:15 am |
N/A 2031-05-17 |
Qualigen Therapeutics Inc. | QLGN | ARSHAD TARIQ SVP/Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 06:14 am |
N/A 2031-05-17 |
Qualigen Therapeutics Inc. | QLGN | ARSHAD TARIQ SVP/Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-29 4:44 pm |
N/A 2030-12-07 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Executive VP, CSO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-08 12:31 pm |
N/A 2030-12-07 |
Qualigen Therapeutics Inc. | QLGN | EMERY SIDNEY W JR Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-12-07 4:32 pm |
N/A N/A |
Qualigen Therapeutics Inc. | QLGN | EMERY SIDNEY W JR Director |
0 | $0 | 19,682 (Direct) |
View |
| 2020-08-27 Option Award |
2020-08-28 2:01 pm |
N/A 2030-08-27 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:27 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Ritter Ira E. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:26 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | David Richard A. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:26 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:24 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Abdul-Ahad Wajdi Vice President, R & D, CSO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:23 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:23 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Sinha Shishir K. Vice President of Operations |
500,000 | $0 | 500,000 (Direct) |
View |